A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome ® in Healthy Subjects
Condition: Bioequivalence Interventions: Drug: Amphotericin B liposome for injection; Drug: AmBisome® Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 6, 2021 Category: Research Source Type: clinical trials
Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal Meningitis
Condition: Cryptococcal Meningitis Intervention: Drug: Amphotericin B 1 mg/kg 1 week& Flucytosine 100 mg/kg 1 week followed by Fluconazole 1200 mg/day 1 week Sponsor: University of Pharmacy, Yangon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials
Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal Meningitis
Condition: Cryptococcal Meningitis Intervention: Sponsor: University of Pharmacy, Yangon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials